Physicians Realty Trust (NYSE:DOC) Receives Consensus Recommendation of “Buy” from Analysts
Physicians Realty Trust (NYSE:DOC) has been assigned an average recommendation of “Buy” from the twenty research firms that are covering the firm. Two research analysts have rated the stock with a sell rating, four have given a hold rating and fourteen have given a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $20.42.
A number of brokerages have recently issued reports on DOC. Wunderlich upped their target price on shares of Physicians Realty Trust from $19.50 to $22.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Cantor Fitzgerald began coverage on shares of Physicians Realty Trust in a report on Thursday, June 23rd. They issued a “buy” rating on the stock. JMP Securities lowered shares of Physicians Realty Trust from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 22nd. TheStreet upgraded shares of Physicians Realty Trust from a “hold” rating to a “buy” rating in a report on Thursday, June 16th. Finally, Citigroup Inc. lowered shares of Physicians Realty Trust from an “outperform” rating to a “market perform” rating in a report on Friday, September 2nd. They noted that the move was a valuation call.
Physicians Realty Trust (NYSE:DOC) traded up 0.66% during trading on Monday, reaching $19.79. 689,354 shares of the company’s stock traded hands. The company has a market cap of $2.65 billion, a P/E ratio of 100.97 and a beta of 0.58. The firm’s 50 day moving average is $21.01 and its 200 day moving average is $20.06. Physicians Realty Trust has a 12 month low of $14.68 and a 12 month high of $22.03.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/10/physicians-realty-trust-nysedoc-receives-consensus-recommendation-of-buy-from-analysts.html
Physicians Realty Trust (NYSE:DOC) last announced its earnings results on Wednesday, August 3rd. The real estate investment trust reported $0.22 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.23 by $0.01. Physicians Realty Trust had a return on equity of 1.59% and a net margin of 11.73%. The company had revenue of $53.20 million for the quarter, compared to analyst estimates of $50.82 million. During the same quarter in the previous year, the company posted $0.18 earnings per share. Physicians Realty Trust’s revenue for the quarter was up 79.3% on a year-over-year basis. Analysts anticipate that Physicians Realty Trust will post $1.03 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 18th. Stockholders of record on Thursday, October 6th will be given a dividend of $0.225 per share. This represents a $0.90 annualized dividend and a dividend yield of 4.58%. The ex-dividend date of this dividend is Tuesday, October 4th. Physicians Realty Trust’s dividend payout ratio is 450.00%.
In related news, insider John T. Thomas sold 15,000 shares of the firm’s stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $21.79, for a total value of $326,850.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.54% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. AXA increased its position in Physicians Realty Trust by 22.2% in the first quarter. AXA now owns 455,313 shares of the real estate investment trust’s stock worth $8,460,000 after buying an additional 82,573 shares during the period. UBS Group AG increased its position in Physicians Realty Trust by 13.2% in the first quarter. UBS Group AG now owns 48,059 shares of the real estate investment trust’s stock worth $893,000 after buying an additional 5,594 shares during the period. State Street Corp increased its position in Physicians Realty Trust by 27.9% in the first quarter. State Street Corp now owns 1,906,707 shares of the real estate investment trust’s stock worth $35,429,000 after buying an additional 415,461 shares during the period. Credit Agricole S A increased its position in Physicians Realty Trust by 46.0% in the first quarter. Credit Agricole S A now owns 37,615 shares of the real estate investment trust’s stock worth $699,000 after buying an additional 11,860 shares during the period. Finally, M&T Bank Corp acquired a new position in Physicians Realty Trust during the first quarter worth $213,000. 94.08% of the stock is owned by institutional investors and hedge funds.
Physicians Realty Trust Company Profile
Physicians Realty Trust is a healthcare real estate company. The Company is engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company’s portfolio includes approximately 150 properties located in approximately 30 states with approximately 5,799,340 net leasable square feet.
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.